SCHEMBL875279

SCHEMBL875279

CC(=O)Nc1cccc(C/C(N)=N/O)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 1/20 0.55
ALDH1A1 P00352 5/20 0.51
NPSR1 Q6W5P4 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.49
RAB9A P51151 3/20 0.49
POLB P06746 1/20 0.49
NR4A1 P22736 1/20 0.49
CYP1A2 P05177 1/20 0.49
HSD17B10 Q99714 1/20 0.49
MEN1 O00255 1/20 0.48
TSHR P16473 1/20 0.48
KMT2A Q03164 1/20 0.48
SIRT2 Q8IXJ6 1/20 0.47
SIRT3 Q9NTG7 1/20 0.47
NOS3 P29474 1/20 0.47
NOS1 P29475 1/20 0.47
NOS2 P35228 1/20 0.47
NLRP3 Q96P20 1/20 0.47
KDM1A O60341 1/20 0.46
NPC1 O15118 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL843452 1.00 AOC3 (0.55) AOC3ALDH1A1NPSR1L3MBTL1RAB9A
SCHEMBL5037396 0.84 ALDH1A1 (0.57) AOC3ALDH1A1NPSR1L3MBTL1RAB9A
SCHEMBL10391003 0.81 ALDH1A1 (0.58) AOC3ALDH1A1NPSR1L3MBTL1RAB9A
SCHEMBL3976944 0.80 NR1H4 (0.61) ALDH1A1NPSR1L3MBTL1RAB9APOLB
SCHEMBL11509658 0.79 NOS3 (0.47) AOC3ALDH1A1NPSR1KMT2ANOS3
SCHEMBL876253 0.78 NR3C1 (0.47) ALDH1A1POLB
SCHEMBL843461 0.78 NR3C1 (0.47) ALDH1A1POLB
SCHEMBL2545099 0.78 ALDH1A1 (0.61) AOC3ALDH1A1NPSR1L3MBTL1RAB9A
SCHEMBL17653723 0.77 SLC7A5 (0.55) AOC3ALDH1A1NPSR1L3MBTL1RAB9A
SCHEMBL30489996 0.77 SLC7A5 (0.55) AOC3ALDH1A1NPSR1L3MBTL1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143264-B2 Xanthine derivatives as selective HM74A agonists GLAXOSMITHKLINE LLC (US) 2012-03-27 US disclosed
US-20110257205-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS GLAXOSMITHKLINE LLC 2011-10-20 US disclosed
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS SMITHKLINE BEECHAM CORPORATION 2010-07-15 US disclosed
US-20100168122-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2010-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168122-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS GPR84, XDH, GPR88 AOC3 859/4885ALDH1A1 514/4885NPSR1 233/4885
US-20110257205-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS GPR84, GPR88, XDH AOC3 1151/4885ALDH1A1 856/4885NPSR1 330/4885
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS XDH, GPR84, GPR88 AOC3 898/4885ALDH1A1 600/4885NPSR1 254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.